Liu Yu
General Information
Title:Professor of Oral and Maxillofacial Surgery, Chief Physician, Doctoral Supervisor
Discipline area:
1. Oral Alveolar and Implant Surgery
2. Hemangiomas
3. Vascular Malformations
Email:liuyu4145@sina.com
Research Profiles:
1. Oral Alveolar Surgery
2. Implant Surgery
3. Hemangiomas
4. Vascular Malformations
Research Expertise
Area of Research Expertise:
RNAi technology was used to block the expression of VEGF and inhibit angiogenesis. Combined with the application of VEGF receptor inhibitor Su6668 to inhibit angiogenesis, it provided new ideas for the treatment of hemangioma.
Research Theme:
Treatment of Hemangioma and Treatment of Vascular Malformations
Academic Publications
1. Liu Y , Sakagami H , Hashimoto K , et al. Tumor-specific cytotoxicity and type of cell death induced by beta-cyclodextrin benzaldehyde inclusion compound.[J]. Anticancer Research, 2008, 28(1A):229.
2. Liu Y , Liu D , Wang Y , et al. Clinical Study of Sclerotherapy of Maxillofacial Venous Malformation Using Absolute Ethanol and Pingyangmycin[J]. J Oral Maxillofac Surg, 2009, 67(1):98-104.
